Riskpilot← Back to searchSign inGet full accessGeomira Terapi AB
ABIn liquidationOrg 5591973143Business and other management consultancy activities · NACE 7022Est. 20191 employees
Revenue 2021
SEK 27K
-93% vs 2020
EBITDA margin
63.0%
+174% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK 13K
+154% vs 2020
| Revenue | SEK 27K | -93% |
| EBITDA | SEK 17K | +174% |
| Net profit | SEK 13K | +154% |
| Total assets | SEK 78K | -10% |
| Equity | SEK 78K | +28% |
| Employees | 1 | — |
Legal name
Geomira Terapi AB
Org number
5591973143
Legal form
Aktiebolag
NACE code
7022 · Business and other management consultancy activities
Founded
5 mars 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Företaget bedriver psykologisk behandling utan läkare i form av: - Samtalsterapi med bland annat KBT och Hypnosterapi - Neurofeedback enligt Othmers metod - Samtalscoachning - Handledning till vårdpersonal som bedriver psykologisk behandling eller verkar inom annan människovårdande verksamhet. Konsultverksamhet i form av: - psykologiska tjänster som behövs inom andra vårdenheter eller andra människovårdande verksamheter.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue | 290 | 399 | 27 |
| Staff expenses | — | — | — |
| EBITDA | 44 | −23 | 17 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 44 | −23 | 17 |
| Net financials | — | — | — |
| Profit before tax | 43 | −24 | 16 |
| Tax | −9 | −0 | −3 |
| Net profit | 34 | −24 | 13 |
| Item | 2019 | 2020 | 2021 |
|---|---|---|---|
| Total assets | 145 | 87 | 78 |
| Equity | 84 | 61 | 78 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 60 | 27 | 0 |
| Total debt | 60 | 27 | — |
EBITDA margin
63.0%
This company
15.8%
Market median
+299% vs market
20192021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192021
Return on equity
16.7%
This company
18.4%
Market median
+9% vs market
20192021
Net profit margin
48.1%
This company
8.1%
Market median
+494% vs market
20192021
Asset turnover
0.35×
This company
1.12×
Market median
-69% vs market
20192021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-03-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CH Liquidator | Liquidator | 2022 |
| Former (1) | ||
AS Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairman | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Geomira Terapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Andreas Segundo Maldonado | Deputy Chief Executive Officer | 0 companies |
| Claes Hellgren | Liquidator | 0 companies |
| Maria Elisabet De Vylder | Chairman | 0 companies |
| Maj Birgitta Hellgren | Deputy Board Member | 0 companies |